MAPVIZO Trademark

Trademark Overview

On Wednesday, July 28, 2021, a trademark application was filed for MAPVIZO with the United States Patent and Trademark Office. The USPTO has given the MAPVIZO trademark a serial number of 90852930. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Monday, October 21, 2024. This trademark is owned by Apellis Pharmaceuticals, Inc.. The MAPVIZO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of complement-mediated diseases and disorders
mapvizo

General Information

Serial Number90852930
Word MarkMAPVIZO
Filing DateWednesday, July 28, 2021
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateMonday, October 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of complement-mediated diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, September 25, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameApellis Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events

Event DateEvent Description
Saturday, July 31, 2021NEW APPLICATION ENTERED
Saturday, September 25, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 8, 2022LETTER OF PROTEST EVIDENCE FORWARDED
Monday, April 25, 2022ASSIGNED TO EXAMINER
Tuesday, April 26, 2022SUSPENSION LETTER WRITTEN
Tuesday, April 26, 2022LETTER OF SUSPENSION E-MAILED
Tuesday, April 26, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, October 24, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, April 24, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, April 26, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, October 24, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, April 22, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, October 21, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Related Keywords

mapvizo diseases disorders mediated complement preparations treatment pharmaceutical